Press release
Personal Care
Essen, October 15, 2020

Evonik expands bio-based portfolio of active ingredients to meet growing demand for sustainable cosmetic and personal care products

Evonik has significantly expanded its bio-based portfolio of active ingredients for cosmetic and personal care markets to meet growing demand for differentiated, sustainably sourced products.

  • Further amplifies Evonik’s ability to help customers transform their brands to generate distinctive sustainability outcomes
  • New platforms for cholesterol specialties and alpha hydroxy acids plus other peptides, plant extracts and hyaluronic acids
  • Sustainability is the key driver of Evonik’s growth division, Nutrition & Care.

This major portfolio expansion follows the acquisition of Wilshire Technologies Inc. earlier this year. It supports the ongoing transformation of Evonik’s growth division, Nutrition & Care, towards its key driver: sustainability. The new bio-based active ingredients of the Care Solutions business line help customers to generate distinctive sustainability outcomes.

In addition to Wilshire, Evonik has made four other strategic acquisitions relating to its Care Solutions business line since 2016 including Air Products and Dr. Straetmans. To further help customers generate distinctive sustainability outcomes, Evonik expects to add other unique active ingredients, intermediates, preservatives and derivatives into its portfolio for cosmetic and personal care applications over the coming year.

“Evonik is rapidly expanding its portfolio to meet growing market demand for bio-based ingredients that can enhance the sustainability, functionality and consumer appeal of cosmetic and personal care products,” said Ricardo Willemann, Vice-President of Active Ingredients at Evonik. “The integration of these new technology platforms and line extensions will further consolidate our position as one of the world’s leading and most trusted suppliers of active ingredients, formulation development and bioanalytical services.”

New platforms of cholesterol specialties and mild, moisture-retaining alpha hydroxy acids, plus a range of peptides, plant extracts and a natural hyaluronic acid, are now available within the active ingredients portfolio of Evonik. These high-quality active ingredients are designed for use across a range of application areas such as premium skin care, advanced cleansers and hair care:

  • Alpha hydroxy acids with milder effects and greater humectant properties to retain moisture
  • Natural hyaluronic acid specialties with excellent moisturization and water retention properties
  • Cholesterol specialties with a high purity
  • Peptides to boost the skin and hair matrix
  • Plant extracts with highly enriched component materials

‘Cosmetic Solutions’ is one of the six innovation growth fields at Evonik that are helping to drive the Company’s future growth. Many of the core competencies that enable these innovation outcomes for cosmetic applications, as well as other growth fields including healthcare, advanced food ingredients, additive manufacturing and sustainable nutrition, reside within the Nutrition & Care division of Evonik.

Company information

Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €13.1 billion and an operating profit (adjusted EBITDA) of €2.15 billion in 2019. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. More than 32,000 employees work together for a common purpose: We want to improve life, today and tomorrow.

Disclaimer

In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.